Use of Non-GAAP Measures 4POLYONE CORPORATION INPUTS FORMULATION EXPERTISE SERVICE VALUE Base resins Additives Modifiers Pigments Expertise in Polymer Materials, Services and Solutions OEMs Brand Owners Processers Assemblers InVisiO SM Color Services IQ Design Labs LSS Customer First Specialty products & services What We Do Driving customer value 5POLYONE CORPORATION $0.13 $0.68 $0.82 $1.00 $1.31 $1.80 $1.96 $2.06 2009 2010 2011 2012 2013 2014 2015 2016* *Recast for DSS in discontinued operations PolyOne At a Glance Performance Products & Solutions 22% PolyOne Distribution 34% Specialty Engineered Materials 18% Color Additives and Inks 26% 2016 Revenue by Segment Adjusted Earnings per Share 2016 Revenue by Geography United States 60% Europe 15% Latin America 9% Canada 7% Asia 10% 6POLYONE CORPORATION 2% 43% 76% 0% 20% 40% 60% 80% 100% 2005 2010 3Q 2017 % o f O p e ra ti n g I n c o m e * *Operating Income excludes corporate charges and special items **LTM 3Q 2017 Specialty OI $5M $87M $275M** JV’s Performance Products & Solutions Specialty MixDistribution Mix Shift Highlights Specialty Transformation Distribution and Contract Manufacturing Businesses 7POLYONE CORPORATION 2014 2015 2016 2017 2014 2015 2016 2017 Driving Growth • Refreshed training curriculum for sales force • Upgraded capabilities to generate and capture new business leads • Expanded R&D resources to focus on key platforms 2014 2015 2016 2017 Investment in Commercial Resources Commercial Resource Additions* Total Sales CallsSales Opportunity Funnel (in billions) *Sales, Marketing & Technology headcount 8POLYONE CORPORATION *ROIC is defined as TTM adjusted OI after tax divided by the sum of average debt and equity less cash over a 5 quarter period Proof of Performance & 2020 Platinum Vision 20%+ 20%+ 12 - 14% 6.5 – 7.5% 15% Consistently Deliver Double Digit Annual EPS Growth 2006 YTD 2017 2020 “Where we were” “Where we are” Platinum Vision ROIC* 5.0% 13.8% Operating Income % of Sales Color, Additives & Inks 1.7% 16.4% Specialty Engineered Materials 1.1% 13.1% Performance Products & Solutions 5.5% 11.4% Distribution 2.6% 6.6% 9POLYONE CORPORATION $50 $116 $137 $0 $40 $80 $120 $160 $200 2012 2014 2016 2017 10.8% 11.3% 12.9% 13.8% 10.0% 11.0% 12.0% 13.0% 14.0% 15.0% 2012 2014 2016 3Q 2017 2020 Platinum Vision Free Cash Flow (in millions) ROIC* *ROIC is defined as TTM adjusted OI after tax divided by the sum of average debt and equity less cash over a 5 quarter period Free Cash Flow and Improving Returns 15.0% >$200 10POLYONE CORPORATION $0.16 $0.20 $0.24 $0.32 $0.40 $0.48 $0.54 $0.70 $- $0.10 $0.20 $0.30 $0.40 $0.50 $0.60 $0.70 $0.80 $0.90 $1.00 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 Annual Dividend 7 Consecutive Years of Increased Dividends 3-Year Dividend Plan  Announced 30% increase to dividend in October 2017, reflecting strong and sustainable cash flow as well as confidence in future earnings growth  Expect to increase annual dividend 60% or more cumulatively over next three years 11POLYONE CORPORATION $767M Returning Cash to Shareholders $0 $150 $300 $450 $600 $750 2011 2012 2013 2014 2015 2016 3Q 2017 Cumulative Share Repurchases (in millions)  Since 2011, we have returned over $950 million to shareholders  $192 million returned through dividends  $767 million returned through share repurchases  Have repurchased 20.8 million shares since early 2013 $767M 12POLYONE CORPORATION  Expanding our sales, marketing, and technical capabilities  Investing in operational and LSS initiatives  ~60 - 70% of capital expenditures fund growth initiatives Organic Growth Acquisitions Share Repurchases Dividends  Targets that expand our: • Specialty offerings • End market presence • Geographic breadth  Growth synergies  Adjacent material solutions  Repurchased 2.0 million shares YTD 2017  Repurchased 20.8 million shares since early 2013  6.5 million shares are available for repurchase under the current authorization  Increased annual dividend by 30% to $0.70 per share, representing the seventh consecutive year of dividend growth Free Cash Flow and Strong Balance Sheet Fund Investment / Shareholder Return 13POLYONE CORPORATION *Specialty Platform revenue from products introduced in last five years Vitality Index Progression* 12% 42% 2006 2016 Target ≥ 35% Innovation Drives Earnings Growth Innovation Pipeline Potential $20 $54 2006 2016 Research & Development Spending ($ millions) Phase 1 Frame Opportunity 12 Projects Phase 2 Build Business Case 10 Projects Phase 3 Prototype 21 Projects Phase 4 Scale-up & Test Market 19 Projects Phase 5 Commercial Launch 10 Projects $500 Million $1.4 Billion $700 Million Total Specialty Addressable Market of over $2.6 Billion 14POLYONE CORPORATION Key Innovation Growth Drivers Composites Barrier Additive Technology Fiber Colorants Flame Retardant Polymers  Increasing regulatory drive for halogen replacements  $400m addressable market  Drive to prevent oxygen, light and UV rays from affecting contents in PET packaging, extending shelf life  $200m addressable market  60% of world fiber consumption is synthetic, need to simplify manufacturing and eliminate waste  $300m addressable market  Polymer formulation and process engineering create a pipeline for next generation materials  Drive to replace aluminum and steel with plastics without compromising on strength 15POLYONE CORPORATION  Providing LSS services to small/medium sized customers  54% of associates trained in LSS, with over 125 active black belts  Have trained over 30 customers in LSS methodology  Providing training in Customer Centric Selling Skills with customers  Providing Industrial design and color services to small/medium sized customers  On time delivery above 95% Strengthening relationships: Customer First Through World-Class Service 16POLYONE CORPORATION  Addressable market exceeds $40 billion  Strong performance demonstrates that our strategy and execution are working  Megatrends and emerging opportunities align with strengths  Innovation and services provide differentiation, incremental pricing power and competitive advantage  Strategic reinvestment for growth while returning cash to shareholders  Strong and proven management team driving growth and performance Why Invest In PolyOne? The New PolyOne: A Specialty Growth Company 17POLYONE CORPORATION Segment Highlights 18POLYONE CORPORATION 1.7% 4.6% 5.1% 5.5% 7.2% 8.1% 9.7% 12.2% 14.7% 16.7% 16.0% 20%+ 16.4% 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 YTD 2017 2020 Operating Income % of Sales 2016 Revenue: $0.8 Billion Key End Markets (% of revenue) United States 45% Europe 33% Asia 15% Latin America 5% Canada 2% Platinum Vision At a Glance Color, Additives & Inks Packaging (30%) Industrial (15%) Wire & Cable (10%) Textiles (9%) Transportation (9%) 19POLYONE CORPORATION 1.1% 1.3% 3.4% 5.1% 9.6% 8.0% 8.6% 9.3% 12.1% 14.7% 14.3% 20%+ 13.1% 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 YTD 2017 2020 Operating Income % of Sales Platinum Vision At a Glance Specialty Engineered Materials 2016 Revenue: $0.6 Billion United States 51% Europe 27% Asia 20% Canada 2% Key End Markets (% of revenue) Consumer (19%) Transportation (19%) Electrical & Electronics (15%) Wire & Cable (15%) Healthcare (11%) 20POLYONE CORPORATION 5.5% 6.9% 3.8% 3.6% 5.5% 4.3% 6.3% 7.2% 7.7% 8.3% 12-14% 11.4% 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 YTD 2017 2020 Operating Income % of Sales 11.1% At a Glance Performance Products & Solutions 2016 Revenue: $0.7 Billion United States 78% Canada 16% Latin America 4% Asia 2% Platinum Vision Key End Markets (% of revenue) Building & Construction (30%) Transportation (18%) Wire & Cable (16%) Industrial (16%) 21POLYONE CORPORATION 4% 36% 2006 2016 At a Glance Distribution 2016 Revenue: $1.1 Billion Key Suppliers ROIC Transportation 24% Healthcare 22% Industrial 18% Consumer 15% Appliance 6% E & E 5% B & C 4% Packaging 4% W & C 2% 2.6% 3.0% 3.5% 4.0% 4.6% 5.6% 6.4% 5.9% 6.1% 6.6% 6.5 - 7.5% 6.4% 6.6% 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 YTD 2017 2020 Operating Income % of Sales *After-Tax ROIC http://www.avient.com/Pages/VariationRoot.aspx http://www.avient.com/Pages/VariationRoot.aspx 22POLYONE CORPORATION Target End Markets & Application Examples 23POLYONE CORPORATION Target End Markets… Healthcare Thermally Conductive Technologies Chemical Resistant Technologies Polymer Colorants Elastomeric Grips and Handles Structural Composites Antimicrobial Technologies Anti-Counterfeiting Technologies 24POLYONE CORPORATION Under-hood Components Target End Markets… Automotive Interior Structural Components Sound & Vibration Management Roof Systems Air Management Electronics and Cameras Lighting Fluid Handling Interior Trim Exterior Trim Braces & Brackets Fasteners Seals & Flaps 25POLYONE CORPORATION Target End Markets… Packaging Oxygen Scavenger Technologies Laser Marking Additives Antistatic Technologies UV Light Barrier Technologies Cap & Closure Colorants Process Optimization Technologies Antioxident Technologies Density Modified Technologies 26POLYONE CORPORATION Target End Markets… Consumer Thermally Conductive Components Polymer Colorants Elastomeric Grips and Handles Structural Composite Components 27POLYONE CORPORATION  Impart weight, sound and metallic finish to caps and closures for cosmetics and spirits applications  Elevate quality and prestige perceptions among high-end consumers  Eliminate time and cost associated with secondary operations and assembly Luxury Packaging GravitechTM Density Modified Polymers 28POLYONE CORPORATION Optimize Color Usage OnColorTM Super Concentrates  Eliminate costs by increasing pigment density  Enhance color performance without altering form and formulation  Increasing design capabilities by reducing weight and layer thickness 29POLYONE CORPORATION Combat Bacteria Formation WithStandTM Antimicrobial Technology  Inhibit microbial growth on polymer surfaces  Enhance value or products and devices  Highly versatile concentrate with the ability to be incorporated into a wide variety of products 30POLYONE CORPORATION Medical Device Housings Chemically Resistant Engineered Polymers  Durable, long-lasting products stand up to the most aggressive disinfectants  Minimize environmental stress cracking and discoloration  One of the broadest medically approved polymer and colorant portfolios 31POLYONE CORPORATION Color & Design Services  Greater control of color development and supply chain  Work across entire design process from concept to commercialization  Inspire creativity in the use of polymer materials, colors, and effects  Innovative brand differentiation  Faster development timelines 32POLYONE CORPORATION Outdoor Applications  Leading provider of high performance specialty materials for the recreational and sports & leisure industry  Well positioned across all segments to address market needs  Metal to Polymer Conversion  Lightweighting  Thermal Management  Impact Performance 33POLYONE CORPORATION  ColorMatrix Fiber Colorant Solutions  Proprietary advanced liquid color formulations and equipment enable greater efficiency and productivity  Eliminates aqueous dyeing and its associated wastewater treatment  Solid Color Concentrates  Extrusion-spun fibers colored via solid masterbatch Fiber Colorants 34POLYONE CORPORATION Smart Home Devices ResilienceTM Vinyl Solutions  High flame retardancy to meet strict UL standards  Greater processing and design flexibility  Specialized additives provide long term color stability  Diffusive lens materials improve light dispersion 1 Reconciliation of Non-GAAP Financial Measures (Unaudited) (Dollars in millions, except per share data) Senior management uses comparisons of adjusted net income from continuing operations attributable to PolyOne common shareholders, adjusted earnings per share (EPS) attributable to PolyOne common shareholders and adjusted earnings before interest, taxes, depreciation and amortization (EBITDA) to assess performance and allocate resources because senior management believes that these measures are useful in understanding current profitability levels and that current levels may serve as a base for future performance.

Avient’s chief operating decision maker uses these financial measures to monitor and evaluate the ongoing performance of Avient and each business segment and to allocate resources. For the same reasons, Avient is unable to address the probable significance of the unavailable information. Avient reflects 2023 adjusted EBITDA guidance of $500M and estimated run-rate CAPEX of $110M. 2023E (%) 27 78 89 83 80 78 74 86 79 76 67 66 55 50 (39) A vi en t K W R FU L P P G A V Y R P M FM C C E E C L A S H H X L H U N E M N S C L Avient Specialty Formulators Other Specialty / Chemical Companies MULTIPLE EXPANSION Source: Peer data per Bloomberg as of 2023年12月29日 Note: Avient reflects 2023 adjusted EBITDA guidance of $500M and closing share price of $41.57.

In addition, the formulation meets ISO 15759 requirements for medical infusion equipment and is manufactured in an ISO 13485 facility. This was achieved, in part, through Avient’s customer service, which offers commercial, logistics and technical support to stopper and cap producers on a global basis. TPE IMPLEMENTATION CONSIDERATIONS Through globally established relationships with toolmakers and machine producers, Avient has a comprehensive understanding of manufacturing challenges and solutions in this arena.

This is to certify that Fiber-Line, LLC 280 Performance Drive SE, Hickory, North Carolina 28602 USA Quality Management System ISO 9001:2015 Manufacture of textile components to cable manufacturers. Certificate No.: CERT-0116814 Original Certification Date: 2010年11月24日 File No.: 1616267 Certification Effective Date: 2021年4月1日 Issue Date: 2021年3月30日 Certificate Expiry Date: 2024年3月31日 ________________________________________________________________________________ ISO 9001 Registered by: QMI-SAI Canada Limited (SAI Global), 20 Carlson Court, Suite 200, Toronto, Ontario M9W 7K6 Canada.

In the event of any claimed conflict between these Terms and any other document not signed by Seller, these Terms shall prevail. Buyer acknowledges that information in Seller’s marketing materials, technical data sheets and other descriptive publications distributed or published on its websites may vary from time to time without no- tice. Buyer acknowledges that Seller has furnished to Buyer Safety Data Sheets, which include warnings to- gether with safety and health information concern- ing the Product and/or the containers for such Prod- uct.

Bergmann GmbH Adolf-Dambach-Str. 2-4 76571 Gaggenau the introduction and application of a management system according to ISO 50001:2018 Scope: DEVELOPMENT AND PRODUCTION OF TECHNICAL POLYMERS The proof has been furnished by an audit.

LIMITATION OF LIABILITY Immediately upon Buyer's acceptance of the Products at the moment of their delivery or collection, Buyer shall indicate in writing on the official delivery or collection documents whether the Products are affected by any apparent damages or defects resulting from their shipment or transportation. SAFETY & HEALTH INDEMNITY Buyer acknowledges that Seller has furnished to Buyer Material Safety Data Sheets as required under applicable laws and regulations, which include warnings together with safety and health information concerning the Product and/or the containers for such Product. DATA PROTECTION Buyer hereby agrees that any data in relation with the business relationship between Buyer and Seller may be processed by Seller, in compliance with applicable laws and regulations. 15.

Condensed Consolidated Statements of Income (Unaudited) (In millions, except per share data) Summary of Special Items (Unaudited) (In millions, except per share data) Condensed Consolidated Balance Sheets (In millions)

主要特性 生产符合高于CAS编号级别的变更控制原则 （与MEVOPUR母粒类似），降低变更风险 不含动物源性物质和邻苯二甲酸盐 适用于吹膜、注塑、吹塑和挤出 • • • 注册药品主文件（III型） 食品接触符合FDA/EU*要求 法规支持 原材料根据以下法规测试：- ISO 10993-1 - USP第、章，包括VI级别，符合眼 科和鼻腔用药物要求 - 欧洲药典3.1.3/3.1.5（聚烯烃） - 美国药典（聚乙烯） - ICH Q3D 杂质元素 - USP和USP，透光率 • • • 载体材料 耐光性 热稳定性 产品代码颜料含量/类型 HDPE 50% TiO2 8 300°C PH00075525 LLDPE 60% TiO2 8 300°C PL00075542 LLDPE 70% TiO2 8 300°C PL00075545 PP 50% TiO2 8 300°C PP00075717 适用医疗保健使用限制—见下文。埃万特的产品不为以下目的或用途而设计，也不会宣传或预期用于以下目的或用途：(a) 被美国食品药品监督管理局（FDA）或国际标准化组织（ISO）归类为“植入”类器械的医疗器械；或美国药典（USP）或ISO标准定义的“永久”使用器械；或 (b) 经修订的欧盟指令90/385/EEC中定义的有源植入式医疗器械；或者 (c) 经修订的欧盟指令93/42/EEC中定义的“长期”使用的医疗器械。

WHO WHERE WHY WHEN The best time to involve Avient Design? Avient makes no representations, guarantees, or warranties of any kind with respect to the information contained in this document about its accuracy, suitability for particular applications, or the results obtained or obtainable using the information. Avient makes no warranties or guarantees respecting suitability of either Avient’s products or the information for your process or end-use application.